The negative prognostic effect of diminished chemotherapy dose intensity is less pronounced in early breast cancer patients experiencing treatment-related neutropenia: findings from a retrospective cohort analysis - Top-Institutions - MDSpire

The negative prognostic effect of diminished chemotherapy dose intensity is less pronounced in early breast cancer patients experiencing treatment-related neutropenia: findings from a retrospective cohort analysis

  • By

  • K. Eissler

  • T. Engler

  • D. Dannehl

  • B. Schönfisch

  • J. Englisch

  • A. D. Hartkopf

  • S. Y. Brucker

  • E. M. Grischke

  • L. L. Volmer

  • Alexander Englisch

  • April 21, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Breast Cancer Research
    • Pharmacodynamics

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Medical Oncology
    • Breast Cancer
    • Supportive Care

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Medical Oncology
    • Breast Cancer
    • Clinical Pharmacology

  • #4

    University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Medical Oncology
    • Breast Cancer Research

  • #5

    University Hospital Tübingen
    University Hospital Tübingen

    Tübingen, Baden-Württemberg

    Key Differentiators

    • Medical Oncology
    • Breast Cancer
    • Clinical Pharmacology

Original Source(s)

The negative prognostic effect of diminished chemotherapy dose intensity is less pronounced in early breast cancer patients experiencing treatment-related neutropenia: findings from a retrospective cohort analysis

  • by K. Eissler, T. Engler, D. Dannehl, B. Schönfisch, J. Englisch, A. D. Hartkopf, S. Y. Brucker, E. M. Grischke, L. L. Volmer, Alexander Englisch

  • April 21, 2026

Related Content

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

Novel approaches for separating graft-versus-leukemia effects from graft-versus-host disease

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review